Oncogene EiC Justin Stebbing, a hypocrite of research integrity?

Oncogene EiC Justin Stebbing, a hypocrite of research integrity?

The cancer research journal Oncogene issued on October 16th 2017 an Editorial on the topic of research integrity:

“The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses”.

The editorial contains a list of 8 common excuses dishonest authors used to escape responsibility for manipulated data. It was authored by David Sanders, virologist and professor at the Department of Biological Sciences at the Purdue University in West Lafayette, Indiana, US, as well as Justin Stebbing, professor of cancer medicine and oncology at the Imperial College London, UK, who is also one of the two Editors-in-Chief (EiC) of the journal Oncogene. Sander is one of these rare brave academics who is unafraid to call out scientific misconduct while his peers hide in the bushes and instead even point fingers at whistleblowers like him. As the newspaper USA Today wrote earlier this year, Sanders made himself a very powerful enemy, the star US cancer researcher with Italian origins, Carlo Croce:

“But that didn’t stop Sanders from alleging that Dr. Carlo Croce, a prominent cancer researcher at Ohio State University, falsified data or plagiarized text in more than two dozen articles Croce has authored. For the past two-plus years, Sanders has contacted scientific journals in which the articles appeared to alert them of his concerns. Earlier this month, he went more public with his claims in an investigative piece by the New York Times that delved into years of ethics charges against Croce.

“There are, and I anticipate there will be additional, consequences for my career,” Sanders said Tuesday afternoon while sitting in his office inside the Hockmeyer Hall of Structural Biology at Purdue.

This isn’t the first time Sanders has publicly accused a scientist of bad behavior. In 2012, Sanders had an article by a former colleague retracted on the basis that the colleague used their former deceased research partner’s data in the paper without permission”.

A long article appeared in The New York Times prior to that, “Years of Ethics Charges, but Star Cancer Researcher Gets a Pass“, detailing the case of Carlo Croce and the role of Sanders the whistleblower, and the Ohio State University, who were mostly covering up the affair. Croce hit back: he is now suing the newspaper, and in separate lawsuit, also Sanders at a New York court, as reported by Retraction Watch.

Hence, Sanders knows first-hand what research misconduct is and how to act upon it. Indeed, the editorial was his idea, and his co-author Stebbing joined afterwards. As Sanders wrote to me:

“The impulse for the editorial and the list was from me.  We discussed the inclusion of particular items and how they were described together”.

Stebbing indeed is not much of a whistleblower, quite the opposite, he can be in fact seen as victim of such. His own publication was heavily criticised on PubPeer, for suspected western blot band duplications. And the piquant bit is: Stebbings, together with his first author  Georgios Giamas (now Reader in Biochemistry at the University of Sussex, UK) offered on PubPeer explanations which sound very much as what he himself has been ridiculing in the Sanders & Stebbing editorial in his journal Oncogene. Continue reading “Oncogene EiC Justin Stebbing, a hypocrite of research integrity?”